The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neuro-Oncological Diseases Device-Global Market Insights and Sales Trends 2025
Synopsis
Neuro-oncological diseases are the disorders that are typically caused due to the growth of a benign or malignant tumor in the brain or any part of the central nervous system. Neuro-oncological tumors are highly fatal, and so their diagnosis becomes a topic of foremost importance. There are a number of neuro-oncological diagnosis devices based on a variety of techniques for the diagnosis of neuro-oncological diseases.
The global Neuro-Oncological Diseases Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neuro-Oncological Diseases Device in various end use industries. The expanding demands from the Hospitals, Clinics, Diagnostics Centers and Reference Laboratories, are propelling Neuro-Oncological Diseases Device market. MRI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CT Scan segment is estimated at % CAGR for the next seven-year period.
The market for neuro-oncological diagnosis devices is most developed in the North American and European region owing to the funds that government provides for research and development of high-quality neuro-oncological diagnosis devices. The market for the devices is also increasing rapidly in Asia Pacific due to new policies of governments which fascinates manufacturers for manufacturing neuro-oncological diagnosis devices in these countries. Neuro-oncological diagnosis device usage is obligatory in the diagnosis of fatal diseases. Therefore, many under-developed economies of middle east and Africa also have a large market for neuro-oncological diagnosis devices.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuro-Oncological Diseases Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuro-Oncological Diseases Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuro-Oncological Diseases Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuro-Oncological Diseases Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuro-Oncological Diseases Device covered in this report include Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare and Hitachi Medical, etc.
The global Neuro-Oncological Diseases Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
GE Healthcare
Hitachi Medical
Global Neuro-Oncological Diseases Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuro-Oncological Diseases Device market, Segment by Type:
MRI
CT Scan
PET
Others
Global Neuro-Oncological Diseases Device market, by Application
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Neuro-Oncological Diseases Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Neuro-Oncological Diseases Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Neuro-oncological diseases are the disorders that are typically caused due to the growth of a benign or malignant tumor in the brain or any part of the central nervous system. Neuro-oncological tumors are highly fatal, and so their diagnosis becomes a topic of foremost importance. There are a number of neuro-oncological diagnosis devices based on a variety of techniques for the diagnosis of neuro-oncological diseases.
The global Neuro-Oncological Diseases Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neuro-Oncological Diseases Device in various end use industries. The expanding demands from the Hospitals, Clinics, Diagnostics Centers and Reference Laboratories, are propelling Neuro-Oncological Diseases Device market. MRI, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CT Scan segment is estimated at % CAGR for the next seven-year period.
The market for neuro-oncological diagnosis devices is most developed in the North American and European region owing to the funds that government provides for research and development of high-quality neuro-oncological diagnosis devices. The market for the devices is also increasing rapidly in Asia Pacific due to new policies of governments which fascinates manufacturers for manufacturing neuro-oncological diagnosis devices in these countries. Neuro-oncological diagnosis device usage is obligatory in the diagnosis of fatal diseases. Therefore, many under-developed economies of middle east and Africa also have a large market for neuro-oncological diagnosis devices.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuro-Oncological Diseases Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuro-Oncological Diseases Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuro-Oncological Diseases Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuro-Oncological Diseases Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuro-Oncological Diseases Device covered in this report include Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare and Hitachi Medical, etc.
The global Neuro-Oncological Diseases Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
GE Healthcare
Hitachi Medical
Global Neuro-Oncological Diseases Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuro-Oncological Diseases Device market, Segment by Type:
MRI
CT Scan
PET
Others
Global Neuro-Oncological Diseases Device market, by Application
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Neuro-Oncological Diseases Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Neuro-Oncological Diseases Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Neuro-Oncological Diseases Device Market Overview
1.1 Neuro-Oncological Diseases Device Product Overview
1.2 Neuro-Oncological Diseases Device Market Segment by Type
1.2.1 MRI
1.2.2 CT Scan
1.2.3 PET
1.2.4 Others
1.3 Global Neuro-Oncological Diseases Device Market Size by Type
1.3.1 Global Neuro-Oncological Diseases Device Market Size Overview by Type (2018-2029)
1.3.2 Global Neuro-Oncological Diseases Device Historic Market Size Review by Type (2018-2023)
1.3.3 Global Neuro-Oncological Diseases Device Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neuro-Oncological Diseases Device Sales Breakdown by Type (2018-2023)
1.4.2 Europe Neuro-Oncological Diseases Device Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Neuro-Oncological Diseases Device Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Neuro-Oncological Diseases Device Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Neuro-Oncological Diseases Device Sales Breakdown by Type (2018-2023)
2 Global Neuro-Oncological Diseases Device Market Competition by Company
2.1 Global Top Players by Neuro-Oncological Diseases Device Sales (2018-2023)
2.2 Global Top Players by Neuro-Oncological Diseases Device Revenue (2018-2023)
2.3 Global Top Players by Neuro-Oncological Diseases Device Price (2018-2023)
2.4 Global Top Manufacturers Neuro-Oncological Diseases Device Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neuro-Oncological Diseases Device Market Competitive Situation and Trends
2.5.1 Neuro-Oncological Diseases Device Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Neuro-Oncological Diseases Device Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuro-Oncological Diseases Device as of 2022)
2.7 Date of Key Manufacturers Enter into Neuro-Oncological Diseases Device Market
2.8 Key Manufacturers Neuro-Oncological Diseases Device Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neuro-Oncological Diseases Device Status and Outlook by Region
3.1 Global Neuro-Oncological Diseases Device Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Neuro-Oncological Diseases Device Historic Market Size by Region
3.2.1 Global Neuro-Oncological Diseases Device Sales in Volume by Region (2018-2023)
3.2.2 Global Neuro-Oncological Diseases Device Sales in Value by Region (2018-2023)
3.2.3 Global Neuro-Oncological Diseases Device Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Neuro-Oncological Diseases Device Forecasted Market Size by Region
3.3.1 Global Neuro-Oncological Diseases Device Sales in Volume by Region (2024-2029)
3.3.2 Global Neuro-Oncological Diseases Device Sales in Value by Region (2024-2029)
3.3.3 Global Neuro-Oncological Diseases Device Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Neuro-Oncological Diseases Device by Application
4.1 Neuro-Oncological Diseases Device Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Diagnostics Centers
4.1.4 Reference Laboratories
4.1.5 Medical Research Institutes
4.1.6 Others
4.2 Global Neuro-Oncological Diseases Device Market Size by Application
4.2.1 Global Neuro-Oncological Diseases Device Market Size Overview by Application (2018-2029)
4.2.2 Global Neuro-Oncological Diseases Device Historic Market Size Review by Application (2018-2023)
4.2.3 Global Neuro-Oncological Diseases Device Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neuro-Oncological Diseases Device Sales Breakdown by Application (2018-2023)
4.3.2 Europe Neuro-Oncological Diseases Device Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Neuro-Oncological Diseases Device Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Neuro-Oncological Diseases Device Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Neuro-Oncological Diseases Device Sales Breakdown by Application (2018-2023)
5 North America Neuro-Oncological Diseases Device by Country
5.1 North America Neuro-Oncological Diseases Device Historic Market Size by Country
5.1.1 North America Neuro-Oncological Diseases Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Neuro-Oncological Diseases Device Sales in Volume by Country (2018-2023)
5.1.3 North America Neuro-Oncological Diseases Device Sales in Value by Country (2018-2023)
5.2 North America Neuro-Oncological Diseases Device Forecasted Market Size by Country
5.2.1 North America Neuro-Oncological Diseases Device Sales in Volume by Country (2024-2029)
5.2.2 North America Neuro-Oncological Diseases Device Sales in Value by Country (2024-2029)
6 Europe Neuro-Oncological Diseases Device by Country
6.1 Europe Neuro-Oncological Diseases Device Historic Market Size by Country
6.1.1 Europe Neuro-Oncological Diseases Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Neuro-Oncological Diseases Device Sales in Volume by Country (2018-2023)
6.1.3 Europe Neuro-Oncological Diseases Device Sales in Value by Country (2018-2023)
6.2 Europe Neuro-Oncological Diseases Device Forecasted Market Size by Country
6.2.1 Europe Neuro-Oncological Diseases Device Sales in Volume by Country (2024-2029)
6.2.2 Europe Neuro-Oncological Diseases Device Sales in Value by Country (2024-2029)
7 Asia-Pacific Neuro-Oncological Diseases Device by Region
7.1 Asia-Pacific Neuro-Oncological Diseases Device Historic Market Size by Region
7.1.1 Asia-Pacific Neuro-Oncological Diseases Device Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Neuro-Oncological Diseases Device Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Neuro-Oncological Diseases Device Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Neuro-Oncological Diseases Device Forecasted Market Size by Region
7.2.1 Asia-Pacific Neuro-Oncological Diseases Device Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Neuro-Oncological Diseases Device Sales in Value by Region (2024-2029)
8 Latin America Neuro-Oncological Diseases Device by Country
8.1 Latin America Neuro-Oncological Diseases Device Historic Market Size by Country
8.1.1 Latin America Neuro-Oncological Diseases Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Neuro-Oncological Diseases Device Sales in Volume by Country (2018-2023)
8.1.3 Latin America Neuro-Oncological Diseases Device Sales in Value by Country (2018-2023)
8.2 Latin America Neuro-Oncological Diseases Device Forecasted Market Size by Country
8.2.1 Latin America Neuro-Oncological Diseases Device Sales in Volume by Country (2024-2029)
8.2.2 Latin America Neuro-Oncological Diseases Device Sales in Value by Country (2024-2029)
9 Middle East and Africa Neuro-Oncological Diseases Device by Country
9.1 Middle East and Africa Neuro-Oncological Diseases Device Historic Market Size by Country
9.1.1 Middle East and Africa Neuro-Oncological Diseases Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Neuro-Oncological Diseases Device Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Neuro-Oncological Diseases Device Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Neuro-Oncological Diseases Device Forecasted Market Size by Country
9.2.1 Middle East and Africa Neuro-Oncological Diseases Device Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Neuro-Oncological Diseases Device Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Siemens Healthcare
10.1.1 Siemens Healthcare Company Information
10.1.2 Siemens Healthcare Introduction and Business Overview
10.1.3 Siemens Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Siemens Healthcare Neuro-Oncological Diseases Device Products Offered
10.1.5 Siemens Healthcare Recent Development
10.2 Philips Healthcare
10.2.1 Philips Healthcare Company Information
10.2.2 Philips Healthcare Introduction and Business Overview
10.2.3 Philips Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Philips Healthcare Neuro-Oncological Diseases Device Products Offered
10.2.5 Philips Healthcare Recent Development
10.3 Canon Medical Systems
10.3.1 Canon Medical Systems Company Information
10.3.2 Canon Medical Systems Introduction and Business Overview
10.3.3 Canon Medical Systems Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Canon Medical Systems Neuro-Oncological Diseases Device Products Offered
10.3.5 Canon Medical Systems Recent Development
10.4 GE Healthcare
10.4.1 GE Healthcare Company Information
10.4.2 GE Healthcare Introduction and Business Overview
10.4.3 GE Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GE Healthcare Neuro-Oncological Diseases Device Products Offered
10.4.5 GE Healthcare Recent Development
10.5 Hitachi Medical
10.5.1 Hitachi Medical Company Information
10.5.2 Hitachi Medical Introduction and Business Overview
10.5.3 Hitachi Medical Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hitachi Medical Neuro-Oncological Diseases Device Products Offered
10.5.5 Hitachi Medical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neuro-Oncological Diseases Device Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neuro-Oncological Diseases Device Industrial Chain Analysis
11.4 Neuro-Oncological Diseases Device Market Dynamics
11.4.1 Neuro-Oncological Diseases Device Industry Trends
11.4.2 Neuro-Oncological Diseases Device Market Drivers
11.4.3 Neuro-Oncological Diseases Device Market Challenges
11.4.4 Neuro-Oncological Diseases Device Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neuro-Oncological Diseases Device Distributors
12.3 Neuro-Oncological Diseases Device Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
